Obesity

Explore the complexities of Obesity research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against Obesity with flcube.com.

EMA's CHMP Backs Indication Extension for Johnson & Johnson's TALVEY – Talquetamab Combination Moves Toward Earlier‑Line Relapsed/Refractory Multiple Myeloma
CompanyDrug

EMA’s CHMP Backs Indication Extension for Johnson & Johnson’s TALVEY – Talquetamab Combination Moves Toward Earlier‑Line Relapsed/Refractory Multiple Myeloma

Johnson & Johnson (J&J; NYSE: JNJ) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of an indication…

Ascentage Pharma Signs Strategic Collaboration with Suzhou University and Its First Affiliated Hospital – Tripartite Partnership Targets Hematologic Oncology Innovation

Ascentage Pharma Signs Strategic Collaboration with Suzhou University and Its First Affiliated Hospital – Tripartite Partnership Targets Hematologic Oncology Innovation

FDA Approves Roche's Enspryng for Thyroid Eye Disease – Satralizumab Becomes First and Only At‑Home Subcutaneous TED Treatment

FDA Approves Roche’s Enspryng for Thyroid Eye Disease – Satralizumab Becomes First and Only At‑Home Subcutaneous TED Treatment

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Hansoh Pharmaceutical Secures Global Licensing Deal with Merck for HS-10535
CompanyDeals

Hansoh Pharmaceutical Secures Global Licensing Deal with Merck for HS-10535

Ascletis Pharma's ASC47 Outperforms Semaglutide in Weight Loss Study
R&D

Ascletis Pharma’s ASC47 Outperforms Semaglutide in Weight Loss Study

Sciwind Biosciences' Ecnoglutide Accepted for Review by NMPA for Weight Management
CompanyDrug

Sciwind Biosciences’ Ecnoglutide Accepted for Review by NMPA for Weight Management

Gan & Lee Pharmaceuticals Gets FDA Approval for GZR18 Obesity/Overweight Phase II Study
CompanyDrug

Gan & Lee Pharmaceuticals Gets FDA Approval for GZR18 Obesity/Overweight Phase II Study

Jiangsu Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-4729 Peptide Drug
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-4729 Peptide Drug

Eli Lilly's Zepbound Outperforms Wegovy in SURMOUNT-5 Weight Loss Study
CompanyDrug

Eli Lilly’s Zepbound Outperforms Wegovy in SURMOUNT-5 Weight Loss Study

Huadong Medicine Receives FDA Clearance for HDM1005 Clinical Study in Obstructive Sleep Apnea
CompanyDeals

Huadong Medicine Receives FDA Clearance for HDM1005 Clinical Study in Obstructive Sleep Apnea

China Medical System Holdings Gets NMPA Approval to Test Obesity Treatment CMS-D005
CompanyDrug

China Medical System Holdings Gets NMPA Approval to Test Obesity Treatment CMS-D005

Show More